ALK receptor tyrosine kinase inhibitors (University of Lyon/Centre National de la Recherche Scientifique/University of Geneva)
N/A
Report date: 2025/03/18 20:00:05
NME
Base Information
Drug NameALK receptor tyrosine kinase inhibitors (University of Lyon/Centre National de la Recherche Scientifique/University of Geneva)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Lyon
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesUniversity Of LyonPulsalysCentre National De La Recherche Scientifique (Cnrs) +[4]
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A